FutureAI

The prevailing advice on Generative AI in MedTech is to launch numerous pilots, encourage widespread experimentation, and wait for the most promising use cases to emerge. That approach sounds innovative, but it is poorly matched to a sector in which evidence provenance, role competence, document status, and change control matter. Medical device manufacturers do not primarily suffer from a shortage of AI demonstrations. They suffer from disconnected evidence, ambiguous accountability, and prototypes that cannot survive design assurance, cybersecurity, privacy, or QMS scrutiny. The more productive view of Generative AI in MedTech begins with an uncomfortable premise: the model is rarely the hardest part. A credible deployment depends on knowing which records are authoritative, which decision a person must retain, how an output will be verified, and what evidence will demonstrate continuing control after a model or source repository changes. Without those foundations, a fluent assistant ...

The prevailing fashion-technology narrative says that retailers should automate more decisions, generate more predictions, and respond to trends faster. That prescription sounds sensible, but it ignores how apparel and footwear value is actually created. Product conviction, range architecture, sourcing feasibility, and controlled scarcity matter as much as forecast accuracy. The strongest AI Use Cases in Fashion therefore do not remove merchant judgment; they make its assumptions visible, testable, and easier to execute across thousands of fragmented style-color-size combinations. A serious assessment of AI Use Cases in Fashion should begin with an uncomfortable question: which decisions genuinely improve when machines make them, and which deteriorate when optimization overwhelms product intent? The answer differs across trend-led collections, continuity basics, technical footwear, and premium capsules. Treating them as one demand problem produces bland assortments, unstable buys, and...